---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-122450"
form_type: "8-K"
ticker: "ISPC"
cik: "0001558569"
company_name: "iSpecimen Inc."
filed_at: "2022-11-28T23:59:59+00:00"
generated_at: "2026-06-21T12:43:58.473217+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# iSpecimen appoints Joseph J. Basile to board, replacing departing director Margaret H. Lawrence

## Summary
- Margaret H. Lawrence resigned as director effective Nov 15, 2022; vacancy filled by Joseph J. Basile effective Nov 28, 2022.
- Mr. Basile appointed to audit committee and nominating & corporate governance committee; independent director under Nasdaq rules.
- Mr. Basile has extensive M&A experience; currently founder of Pari Passu M&A Mediation and Senior Advisor at Hogan Lovells.
- No family relationships or transactions with the company; standard director indemnification agreement entered.

## SEC filing metadata
- accession: 0001104659-22-122450
- form_type: 8-K
- ticker: ISPC
- cik: 0001558569
- company_name: iSpecimen Inc.
- filed_at: 2022-11-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/0001104659-22-122450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/tm2231481d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-122450
- JSON: https://secwatch.observer/filing/0001104659-22-122450.json
- Plain text: https://secwatch.observer/filing/0001104659-22-122450.txt

## Key facts
- Executive change
  Margaret H. Lawrence resigned as Director at iSpecimen Inc..
  - Action: resigned
  - Role: Director
  source text: Margaret H. Lawrence informed the Board of Directors (the “Board”) of the Company of her intention to resign as a director of the Company effective November 15, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/0001104659-22-122450-index.htm
- Executive change
  Joseph J. Basile was appointed as Director at iSpecimen Inc..
  - Action: appointed
  - Role: Director
  source text: approved the appointment of Joseph J. Basile to serve as a member of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465922122450/0001104659-22-122450-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.